Location: New York, NY
CIK: 0001493215 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $6.613B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,993,687 | $615M | 9.3% | $231.65 | +21.4% | COM | 558868105 |
| ARGX | ARGENX SE | 673,497 | $414M | 6.3% | $351.97 | — | SPONSORED ADR | 04016X101 |
| NTRA | NATERA INC | 2,593,323 | $411M | 6.2% | $42.76 | +240.6% | COM | 632307104 |
| AXSM | AXSOME THERAPEUTICS INC | 4,051,365 | $343M | 5.2% | $56.00 | +64.2% | COM | 05464T104 |
| PTCT | PTC THERAPEUTICS INC | 7,393,127 | $334M | 5.0% | $38.04 | +12.5% | COM | 69366J200 |
| RNAM | AVIDITY BIOSCIENCES INC | 7,932,870 | $231M | 3.5% | $23.99 | +74.2% | COM | 05370A108 |
| RCKT | ROCKET PHARMACEUTICALS INC | 17,687,772 | $222M | 3.4% | $17.75 | -15.2% | COM | 77313F106 |
| ALKS | ALKERMES PLC | 7,557,835 | $217M | 3.3% | $27.15 | +5.9% | SHS | G01767105 |
| SYK | STRYKER CORPORATION | 590,221 | $213M | 3.2% | $348.93 | +5.0% | COM | 863667101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,498,545 | $212M | 3.2% | $22.73 | +91.8% | COM | 74366E102 |
| INSM | INSMED INC | 3,014,558 | $208M | 3.1% | $29.56 | +143.6% | COM PAR $.01 | 457669307 |
| PEN | PENUMBRA INC | 862,450 | $205M | 3.1% | $247.59 | -8.2% | COM | 70975L107 |
| — | AKERO THERAPEUTICS INC | 6,859,823 | $191M | 2.9% | $24.85 | — | COM | 00973Y108 |
| TARS | TARSUS PHARMACEUTICALS INC | 3,236,549 | $179M | 2.7% | $24.90 | +82.4% | COM | 87650L103 |
| — | MERUS N V | 4,169,393 | $175M | 2.7% | $34.07 | — | COM | N5749R100 |
| ACAD | ACADIA PHARMACEUTICALS INC | 8,705,501 | $160M | 2.4% | $21.38 | -24.5% | COM | 004225108 |
| BRKR | BRUKER CORP | 2,481,119 | $145M | 2.2% | $72.91 | -19.4% | COM | 116794108 |
| IMCR | IMMUNOCORE HLDGS PLC | 4,869,798 | $144M | 2.2% | $43.23 | — | ADS | 45258D105 |
| RDNT | RADNET INC | 1,978,582 | $138M | 2.1% | $41.39 | +78.2% | COM | 750491102 |
| CYTK | CYTOKINETICS INC | 2,721,158 | $128M | 1.9% | $29.14 | +78.2% | COM NEW | 23282W605 |
| DYN | DYNE THERAPEUTICS INC | 5,218,641 | $123M | 1.9% | $26.82 | +10.3% | COM | 26818M108 |
| APGE | APOGEE THERAPEUTICS INC | 2,712,097 | $123M | 1.9% | $27.01 | +88.8% | COM | 03770N101 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 2,569,687 | $118M | 1.8% | $28.18 | +54.7% | COM | G31249108 |
| MASI | MASIMO CORP | 683,294 | $113M | 1.7% | $166.52 | -5.2% | COM | 574795100 |
| — | VERONA PHARMA PLC | 1,821,019 | $84.57M | 1.3% | $46.44 | — | SPONSORED ADS | 925050106 |
| SYRE | SPYRE THERAPEUTICS INC | 3,621,996 | $84.32M | 1.3% | $20.99 | +39.7% | COM NEW | 00773J202 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 1,968,002 | $82.79M | 1.3% | $50.54 | -1.8% | COM | 90400D108 |
| GMED | GLOBUS MED INC | 972,000 | $80.39M | 1.2% | $78.87 | 0.0% | CL A | 379577208 |
| ZLAB | ZAI LAB LTD | 2,509,119 | $65.71M | 1.0% | $26.19 | — | ADR | 98887Q104 |
| ARVN | ARVINAS INC | 3,334,308 | $63.92M | 1.0% | $23.53 | +3.3% | COM | 04335A105 |
| — | CARGO THERAPEUTICS INC | 4,124,859 | $59.48M | 0.9% | $22.58 | — | COM | 14179K101 |
| — | 89BIO INC | 7,478,061 | $58.48M | 0.9% | $11.24 | — | COM | 282559103 |
| STOK | STOKE THERAPEUTICS INC | 5,123,525 | $56.51M | 0.9% | $22.20 | -44.7% | COM | 86150R107 |
| XNCR | XENCOR INC | 2,402,883 | $55.22M | 0.8% | $21.97 | +4.6% | COM | 98401F105 |
| CGON | CG ONCOLOGY INC | 1,701,216 | $48.79M | 0.7% | $36.07 | -5.1% | COM | 156944100 |
| IMTX | IMMATICS N.V | 6,540,540 | $46.5M | 0.7% | $11.40 | -24.6% | SHS | N44445109 |
| URGN | UROGEN PHARMA LTD | 3,834,794 | $40.84M | 0.6% | $15.16 | -21.0% | COM | M96088105 |
| ORKA | ORUKA THERAPEUTICS INC | 1,945,649 | $37.73M | 0.6% | $34.29 | -28.8% | COM | 687604108 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 8,206,162 | $32.82M | 0.5% | $10.21 | -47.4% | COM | 68572M106 |
| NGNE | NEUROGENE INC | 1,350,256 | $30.87M | 0.5% | $34.68 | +7.3% | COM | 64135M105 |
| REPL | REPLIMUNE GROUP INC | 2,065,010 | $25.01M | 0.4% | $9.31 | +30.6% | COM | 76029N106 |
| LENZ | LENZ THERAPEUTICS INC | 863,389 | $24.93M | 0.4% | $20.79 | +46.6% | COM | 52635N103 |
| GHRS | GH RESEARCH PLC | 3,327,129 | $23.29M | 0.4% | $17.34 | -53.6% | ORDINARY SHARES | G3855L106 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,705,960 | $20.78M | 0.3% | $19.93 | -27.9% | COM | 230031106 |
| — | RAPT THERAPEUTICS INC | 11,764,000 | $18.59M | 0.3% | $1.58 | — | COM | 75382E109 |
| ROIV | ROIVANT SCIENCES LTD | 1,454,273 | $17.2M | 0.3% | $8.28 | +42.8% | SHS | G76279101 |
| — | SAGE THERAPEUTICS INC | 3,002,370 | $16.3M | 0.2% | $20.22 | — | COM | 78667J108 |
| QURE | UNIQURE NV | 903,625 | $15.96M | 0.2% | $8.61 | +0.3% | SHS | N90064101 |
| TSHA | TAYSHA GENE THERAPIES INC | 8,672,630 | $15M | 0.2% | $1.90 | +9.2% | COM SHS | 877619106 |
| — | TOURMALINE BIO INC | 736,681 | $14.94M | 0.2% | $24.66 | — | COM | 89157D105 |
| DNTH | DIANTHUS THERAPEUTICS INC | 666,667 | $14.53M | 0.2% | $21.73 | +18.3% | COM | 252828108 |
| CRVS | CORVUS PHARMACEUTICALS INC | 2,679,479 | $14.34M | 0.2% | $7.47 | 0.0% | COM | 221015100 |
| IMVT | IMMUNOVANT INC | 530,614 | $13.14M | 0.2% | $28.37 | 0.0% | COM | 45258J102 |
| PEPG | PEPGEN INC | 3,193,097 | $12.1M | 0.2% | $6.23 | 0.0% | COM | 713317105 |
| CMPS | COMPASS PATHWAYS PLC | 3,098,987 | $11.71M | 0.2% | $3.78 | — | SPONSORED ADS | 20451W101 |
| WVE | WAVE LIFE SCIENCES LTD | 900,000 | $11.13M | 0.2% | $5.98 | +123.3% | SHS | Y95308105 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 742,500 | $7.559M | 0.1% | $10.07 | +0.3% | CL A ORD SHS | G70077105 |
| XGN | EXAGEN INC | 1,511,866 | $6.199M | 0.1% | $11.83 | -69.5% | COM | 30068X103 |
| MIST | MILESTONE PHARMACEUTICALS IN | 2,506,102 | $5.914M | 0.1% | $20.06 | -91.4% | COM | 59935V107 |
| IDYA | IDEAYA BIOSCIENCES INC | 200,000 | $5.14M | 0.1% | $37.92 | -25.3% | COM | 45166A102 |
| IMUX | IMMUNIC INC | 4,567,717 | $4.568M | 0.1% | $8.52 | -85.2% | COM | 4525EP101 |
| BIOA | BIOAGE LABS INC | 786,353 | $4.553M | 0.1% | $20.04 | -13.9% | COM | 09077V100 |
| CBLL | CERIBELL INC | 150,000 | $3.882M | 0.1% | $27.25 | 0.0% | COM | 15678C102 |
| GPCR | STRUCTURE THERAPEUTICS INC | 125,000 | $3.39M | 0.1% | $39.27 | — | SPONSORED ADS | 86366E106 |
| — | ACELYRIN INC | 978,310 | $3.072M | 0.0% | $20.90 | — | COM | 00445A100 |
| RGNX | REGENXBIO INC | 350,000 | $2.705M | 0.0% | $17.79 | -47.2% | COM | 75901B107 |
| — | ESSA PHARMA INC | 1,113,002 | $1.992M | 0.0% | $6.44 | — | COM NEW | 29668H708 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 148,844 | $1.5M | 0.0% | $11.59 | +3.6% | COM | 04317A107 |
| — | ALLURION TECHNOLOGIES INC | 2,947,551 | $1.267M | 0.0% | $4.09 | — | COM SHS | 02008G102 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 50,000 | $838K | 0.0% | $15.99 | — | SPONSORED ADS | 152309100 |
| ADGM | ADAGIO MED HLDGS INC | 209,361 | $220K | 0.0% | $4.76 | -49.3% | COM | 00534B100 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 350,000 | $12,005 | 0.0% | $0.11 | — | *W EXP 09/02/202 | 77313F114 |